Ophthalmology Devices Global Market – Forecast To 2021
Ophthalmology is a segment of medical science associated with study of anatomy, physiology, diseases of human eye, and developing various therapeutic methods to treat eye diseases. Some of the major eye diseases are either age-related or caused due to chronic disorders. They include various degenerative eye diseases like macular degeneration, cataract, ocular hypertension (glaucoma), and refractive errors among others. Revolution in the field of medical science has led to the rapid development of ophthalmology devices that are invented to effectively treat ocular defects and disorders.
Ophthalmology devices market is segmented on the basis of products type as diagnostic devices, surgical devices and vision care. Based on the applications the ophthalmology devices market is segmented into cataract, glaucoma, age-related macular degeneration, diabetes retinopathy and others (refractive errors, amblyopia, and strabismus). End-users are segmented into hospitals, academic and research laboratories, and others (private eye clinic and vision care outlets).
The global ophthalmology devices market is expected to grow at a CAGR of around 5.8% from 2015 to 2021. Increasing incidence of degenerative diseases of eyes, increasing baby boomer population, increase in R&D activities in ophthalmology key players and extensive use of high-end technologies involving use of software and computer aided devices and platforms in ophthalmology drives the market of ophthalmology devices market. Lack of ophthalmologists, economic slowdown and saturation of the market in developed countries are the factors hampering the market growth.
Lifestyle changes owing to increase in ocular cancer, diabetes and macular degeneration patients, early diagnosis and treatment of diseases, advancement of technology with its wide application areas shows that ophthalmology devices market has vast opportunities in the coming years.
North America accounts for the highest market share followed by Europe. Steep rise in ageing population, increase in minimally invasive surgeries and favourable government policies makes U.S. the leader of ophthalmology devices market. However, Asian countries especially India and China’s are the fast growing regions with its growing demand for ophthalmology devices and increasing research investments.
Major players in ophthalmology devices market include Abbott Medical Optics, Inc. (U.S.), Alcon Laboratories, Inc. (U.S.), Bausch & Lomb, Inc. (U.S.), Carl Zeiss (Germany), Essilor International SA (U.S.), Haag-Streit Holding AG (Switzerland), Hoya Corporation (Japan), Nidek Co. Ltd (Japan), STAAR Surgicals (U.S.) and Topcon Corporation (Japan).
Ophthalmology devices market is segmented on the basis of products type as diagnostic devices, surgical devices and vision care. Based on the applications the ophthalmology devices market is segmented into cataract, glaucoma, age-related macular degeneration, diabetes retinopathy and others (refractive errors, amblyopia, and strabismus). End-users are segmented into hospitals, academic and research laboratories, and others (private eye clinic and vision care outlets).
The global ophthalmology devices market is expected to grow at a CAGR of around 5.8% from 2015 to 2021. Increasing incidence of degenerative diseases of eyes, increasing baby boomer population, increase in R&D activities in ophthalmology key players and extensive use of high-end technologies involving use of software and computer aided devices and platforms in ophthalmology drives the market of ophthalmology devices market. Lack of ophthalmologists, economic slowdown and saturation of the market in developed countries are the factors hampering the market growth.
Lifestyle changes owing to increase in ocular cancer, diabetes and macular degeneration patients, early diagnosis and treatment of diseases, advancement of technology with its wide application areas shows that ophthalmology devices market has vast opportunities in the coming years.
North America accounts for the highest market share followed by Europe. Steep rise in ageing population, increase in minimally invasive surgeries and favourable government policies makes U.S. the leader of ophthalmology devices market. However, Asian countries especially India and China’s are the fast growing regions with its growing demand for ophthalmology devices and increasing research investments.
Major players in ophthalmology devices market include Abbott Medical Optics, Inc. (U.S.), Alcon Laboratories, Inc. (U.S.), Bausch & Lomb, Inc. (U.S.), Carl Zeiss (Germany), Essilor International SA (U.S.), Haag-Streit Holding AG (Switzerland), Hoya Corporation (Japan), Nidek Co. Ltd (Japan), STAAR Surgicals (U.S.) and Topcon Corporation (Japan).
1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS
3.3.1.1 Increasing baby boomer population and incidence of degenerative diseases of eyes
3.3.1.2 Increase in r&d activities by ophthalmology key players
3.3.1.3 Extensive use of high-end technologies involving use of software and computer aided devices and platforms
3.3.1.4 Untapped emerging markets
3.3.1.5 Development of minimal invasive surgery
3.3.2 RESTRAINTS
3.3.2.1 Lack of ophthalmologists
3.3.2.2 Economic slowdown and saturation of the market in developed countries
3.3.2.3 Reimbursement cuts
3.3.3 THREATS
3.3.3.1 Intensified competition
3.3.4 CHALLENGES
3.3.4.1 Lack of insurance coverage in developing countries and insufficient coverage for iols in developed countries
3.3.4.2 Extended timelines of device approval
3.4 REGULATORY AFFAIRS
3.4.1 U.S.
3.4.2 EUROPE
3.4.3 CHINA
3.4.4 INDIA
3.4.5 JAPAN
3.5 REIMBURSEMENT SCENARIO
3.5.1 REIMBURSEMENT Table
3.6 PATENT TRENDS
3.7 TECHNOLOGICAL ADVANCEMENTS
3.8 UPCOMING TECHNOLOGIES
3.9 PORTER’S FIVE FORCE ANALYSIS
3.9.1 THREAT OF NEW ENTRANTS
3.9.2 THREAT OF SUBSTITUTES
3.9.3 RIVALRY AMONG EXISTING COMPETITORS
3.9.4 BARGAINING POWER OF SUPPLIERS
3.9.5 BARGAINING POWER OF BUYERS
3.10 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
4 GLOBAL OPHTHALMOLOGY DEVICES MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.1.1 GLOBAL OPHTHALMOLOGY DIAGNOSTIC DEVICES BY PRODUCT TYPES
4.1.1.1 Autorefractors
4.1.1.2 Slit lamp
4.1.1.3 Tonometer
4.1.1.4 Ophthalmoscope
4.1.1.5 Keratometer
4.1.1.6 Corneal topographer
4.1.1.7 Optical coherence tomography (OCT)
4.1.1.8 Fundus camera
4.1.1.8.1 Non-mydriatic fundus cameras
4.1.1.8.2 Mydriatic fundus cameras
4.1.1.8.3 Hybrid fundus cameras
4.1.1.8.4 Retinopathy of prematurity (ROP)
4.1.1.9 Ophthalmic ultrasound imaging system
4.1.1.10 Retinoscope
4.1.1.11 Perimeter
4.1.1.12 Pachymeter
4.1.1.13 Others
4.1.1.13.1 Snellen chart
4.1.1.13.2 Amsler grid eye test
4.1.1.13.3 Wavefront aberrometer
4.1.1.13.4 Point of care devices
4.1.2 GLOBAL OPHTHALMIC SURGICAL DEVICES MARKET
4.1.2.1 Introduction
4.1.2.2 Cataract surgery devices
4.1.2.2.1 Intraocular lens (IOL)
4.1.2.2.2 Phacoemulsification
4.1.2.2.3 OVDS (OPHTHALMIC VISCOSURGICAL DEVICES)
4.1.2.2.4 YAG Laser
4.1.2.3 Glaucoma surgery devices
4.1.2.3.1 Glaucoma lasers
4.1.2.3.2 Glaucoma surgery
4.1.2.3.3 Glaucoma implants
4.1.2.3.4 Glaucoma systems
4.1.2.4 Refractive error surgical devices
4.1.2.4.1 Photorefractive keratectomy (PRK)
4.1.2.4.2 Laser assisted sub-epithelium keratomileusis (LASEK)
4.1.2.4.3 Laser assisted insitu keratomileusis (LASIK)
4.1.2.4.4 Femtosecond laser
4.1.2.4.5 Epi-LASIK
4.1.2.4.6 Phakic intraocular lens (PIOLS)
4.1.2.5 Vitreoretinal surgical devices
4.1.2.5.1 Vitrectomy
4.1.2.5.2 Photocoagulation
4.1.2.5.3 Illumination
4.1.3 GLOBAL VISION CARE DEVICES
4.1.3.1 Introduction
4.1.3.2 Spectacle lenses
4.1.3.3 Contact lenses
5 OPHTHALMOLOGY DEVICES GLOBAL MARKET, BY APPLICATIONS
5.1 INTRODUCTION
5.2 CATARACT
5.3 GLAUCOMA
5.4 AGE RELATED MACULAR DEGENERATION
5.5 DIABETIC RETINOPATHY (DR)
5.6 OTHERS (REFRACTIVE ERRORS, AMBLYOPIA, STRABISMUS)
6 OPHTHALMOLOGY DEVICES GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 ACADEMIC & RESEARCH LABORATORIES
6.4 OTHERS
7 REGIONAL ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 CANADA
7.3 EUROPE
7.4 ASIA PACIFIC
7.5 REST OF THE WORLD
8 COMPANY DEVELOPMENTS
8.1 INTRODUCTION
8.2 NEW PRODUCT LAUNCHES
8.3 AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES
8.4 APPROVALS
8.5 MERGERS & ACQUISITIONS
9 MAJOR COMPANIES
9.1 ABBOTT LABORATORIES
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 NOVARTIS AG
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 VALEANT PHARMACEUTICALS INTERNATIONAL, INC
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 CARL ZEISS AG
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 ESSILOR INTERNATIONAL
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCTS PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 HAAG-STREIT HOLDING AG.
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 HOYA CORPORATION
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCTS PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 JOHNSON & JOHNSON
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 NIDEK CO., LTD
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.10 STAAR SURGICAL COMPANY
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
9.11 TOPCON CORPORATION
9.11.1 OVERVIEW
9.11.2 FINANCIALS
9.11.3 PRODUCT PORTFOLIO
9.11.4 KEY DEVELOPMENTS
9.11.5 BUSINESS STRATEGY
9.11.6 SWOT ANALYSIS
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS
3.3.1.1 Increasing baby boomer population and incidence of degenerative diseases of eyes
3.3.1.2 Increase in r&d activities by ophthalmology key players
3.3.1.3 Extensive use of high-end technologies involving use of software and computer aided devices and platforms
3.3.1.4 Untapped emerging markets
3.3.1.5 Development of minimal invasive surgery
3.3.2 RESTRAINTS
3.3.2.1 Lack of ophthalmologists
3.3.2.2 Economic slowdown and saturation of the market in developed countries
3.3.2.3 Reimbursement cuts
3.3.3 THREATS
3.3.3.1 Intensified competition
3.3.4 CHALLENGES
3.3.4.1 Lack of insurance coverage in developing countries and insufficient coverage for iols in developed countries
3.3.4.2 Extended timelines of device approval
3.4 REGULATORY AFFAIRS
3.4.1 U.S.
3.4.2 EUROPE
3.4.3 CHINA
3.4.4 INDIA
3.4.5 JAPAN
3.5 REIMBURSEMENT SCENARIO
3.5.1 REIMBURSEMENT Table
3.6 PATENT TRENDS
3.7 TECHNOLOGICAL ADVANCEMENTS
3.8 UPCOMING TECHNOLOGIES
3.9 PORTER’S FIVE FORCE ANALYSIS
3.9.1 THREAT OF NEW ENTRANTS
3.9.2 THREAT OF SUBSTITUTES
3.9.3 RIVALRY AMONG EXISTING COMPETITORS
3.9.4 BARGAINING POWER OF SUPPLIERS
3.9.5 BARGAINING POWER OF BUYERS
3.10 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
4 GLOBAL OPHTHALMOLOGY DEVICES MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.1.1 GLOBAL OPHTHALMOLOGY DIAGNOSTIC DEVICES BY PRODUCT TYPES
4.1.1.1 Autorefractors
4.1.1.2 Slit lamp
4.1.1.3 Tonometer
4.1.1.4 Ophthalmoscope
4.1.1.5 Keratometer
4.1.1.6 Corneal topographer
4.1.1.7 Optical coherence tomography (OCT)
4.1.1.8 Fundus camera
4.1.1.8.1 Non-mydriatic fundus cameras
4.1.1.8.2 Mydriatic fundus cameras
4.1.1.8.3 Hybrid fundus cameras
4.1.1.8.4 Retinopathy of prematurity (ROP)
4.1.1.9 Ophthalmic ultrasound imaging system
4.1.1.10 Retinoscope
4.1.1.11 Perimeter
4.1.1.12 Pachymeter
4.1.1.13 Others
4.1.1.13.1 Snellen chart
4.1.1.13.2 Amsler grid eye test
4.1.1.13.3 Wavefront aberrometer
4.1.1.13.4 Point of care devices
4.1.2 GLOBAL OPHTHALMIC SURGICAL DEVICES MARKET
4.1.2.1 Introduction
4.1.2.2 Cataract surgery devices
4.1.2.2.1 Intraocular lens (IOL)
4.1.2.2.2 Phacoemulsification
4.1.2.2.3 OVDS (OPHTHALMIC VISCOSURGICAL DEVICES)
4.1.2.2.4 YAG Laser
4.1.2.3 Glaucoma surgery devices
4.1.2.3.1 Glaucoma lasers
4.1.2.3.2 Glaucoma surgery
4.1.2.3.3 Glaucoma implants
4.1.2.3.4 Glaucoma systems
4.1.2.4 Refractive error surgical devices
4.1.2.4.1 Photorefractive keratectomy (PRK)
4.1.2.4.2 Laser assisted sub-epithelium keratomileusis (LASEK)
4.1.2.4.3 Laser assisted insitu keratomileusis (LASIK)
4.1.2.4.4 Femtosecond laser
4.1.2.4.5 Epi-LASIK
4.1.2.4.6 Phakic intraocular lens (PIOLS)
4.1.2.5 Vitreoretinal surgical devices
4.1.2.5.1 Vitrectomy
4.1.2.5.2 Photocoagulation
4.1.2.5.3 Illumination
4.1.3 GLOBAL VISION CARE DEVICES
4.1.3.1 Introduction
4.1.3.2 Spectacle lenses
4.1.3.3 Contact lenses
5 OPHTHALMOLOGY DEVICES GLOBAL MARKET, BY APPLICATIONS
5.1 INTRODUCTION
5.2 CATARACT
5.3 GLAUCOMA
5.4 AGE RELATED MACULAR DEGENERATION
5.5 DIABETIC RETINOPATHY (DR)
5.6 OTHERS (REFRACTIVE ERRORS, AMBLYOPIA, STRABISMUS)
6 OPHTHALMOLOGY DEVICES GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 ACADEMIC & RESEARCH LABORATORIES
6.4 OTHERS
7 REGIONAL ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 CANADA
7.3 EUROPE
7.4 ASIA PACIFIC
7.5 REST OF THE WORLD
8 COMPANY DEVELOPMENTS
8.1 INTRODUCTION
8.2 NEW PRODUCT LAUNCHES
8.3 AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES
8.4 APPROVALS
8.5 MERGERS & ACQUISITIONS
9 MAJOR COMPANIES
9.1 ABBOTT LABORATORIES
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 NOVARTIS AG
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 VALEANT PHARMACEUTICALS INTERNATIONAL, INC
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 CARL ZEISS AG
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 ESSILOR INTERNATIONAL
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCTS PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 HAAG-STREIT HOLDING AG.
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 HOYA CORPORATION
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCTS PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 JOHNSON & JOHNSON
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 NIDEK CO., LTD
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.10 STAAR SURGICAL COMPANY
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
9.11 TOPCON CORPORATION
9.11.1 OVERVIEW
9.11.2 FINANCIALS
9.11.3 PRODUCT PORTFOLIO
9.11.4 KEY DEVELOPMENTS
9.11.5 BUSINESS STRATEGY
9.11.6 SWOT ANALYSIS
LIST OF TABLES
Table 1 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 2 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2013-2021) ($MN)
Table 3 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY APPLICATIONS, (2013-2021) ($MN)
Table 4 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2013-2021) ($MN)
Table 5 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2013-2021) ($MN)
Table 6 DIAGNOSTIC DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 7 AUTOREFRACTOMETER GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 8 SLIT LAMP GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 9 TONOMETERS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 10 OPHTHALMOSCOPE GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 11 KERATOMETER GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 12 CORNEAL TOPOGRAPHER GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 13 OPTICAL COHERENCE TOMOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 14 FUNDUS CAMERA GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 15 FUNDUS CAMERA GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 16 NON-MYDRIATIC FUNDUS CAMERA GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 17 MYDRIATIC FUNDUS CAMERA GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 18 HYBRID FUNDUS CAMERA GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 19 RETINOPATHY OF PREMATURITY GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 20 OPHTHALMIC ULTRASOUND IMAGING SYSTEM GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 21 RETINOSCOPE GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 22 PERIMETER GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 23 PACHYMETER GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 24 OTHERS (DIAGNOSTICS) GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 25 SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 26 SURGICAL DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 27 CATARACT SURGICAL DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 28 CATARACT SURGERY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 29 IOL GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 30 PHACOEMULSIFICATION GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 31 OVD GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 32 GLACOMA SURGERY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 33 REFRACTIVE SURGERY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 34 VITREORETINAL SURGERY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 35 VISION CARE GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 36 VISION CARE GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 37 SPECTACLE LENSES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 38 CONTACT LENSES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 39 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN)
Table 40 CATARACT GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 41 GLAUCOMA GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 42 AGE RELATED MACULAR DEGENERATION MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 43 DIABETIC RETINOPATHY GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 44 OTHERS (APPLICATIONS) GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 45 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2013-2021) ($MN)
Table 46 HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 47 ACADEMICS & RESEARCH LABORATORIES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 48 OTHER END USERS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 49 NORTH AMERICAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2013-2021) ($MN)
Table 50 NORTH AMERICAN DIAGNOSTIC DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 51 NORTH AMERICAN FUNDUS CAMERAS MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 52 NORTH AMERICAN SURGICAL DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 53 NORTH AMERICAN CATARACT SURGERY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 54 NORTH AMERICAN VISION CARE MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 55 NORTH AMERICAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN)
Table 56 NORTH AMERICAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY END-USER, (2013-2021) ($MN)
Table 57 EUROPEAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 58 EUROPEAN DIAGNOSTIC DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 59 EUROPEAN FUNDUS CAMERAS MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 60 EUROPEAN SURGICAL DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 61 EUROPEAN CATARACT SURGERY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 62 EUROPEAN VISION CARE MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 63 EUROPEAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN)
Table 64 EUROPEAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY END-USERS, (2013-2021) ($MN)
Table 65 ASIA-PACIFIC OPHTHALMOLOGY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 66 ASIA-PACIFIC DIAGNOSTIC DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 67 ASIA-PACIFIC FUNDUS CAMERAS MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 68 ASIA-PACIFIC SURGICAL DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 69 ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 70 ASIA-PACIFIC VISION CARE MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 71 ASIA-PACIFIC OPHTHALMOLOGY DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN)
Table 72 ASIA-PACIFIC OPHTHALMOLOGY DEVICES MARKET REVENUE, BY END-USERS, (2013-2021) ($MN)
Table 73 ROW OPHTHALMOLOGY DEVICES MARKET REVENUE, BY TYPE (2013-2021) ($MN)
Table 74 ROW DIAGNOSTICS DEVICES MARKET REVENUE, BY TYPES, (2013-2021) ($MN)
Table 75 ROW FUNDUS CAMERAS MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 76 ROW SURGICAL DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 77 ROW CATARACT SURGERY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 78 ROW VISION CARE MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 79 ROW OPHTHALMOLOGY DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN)
Table 80 ROW OPHTHALMOLOGY DEVICES MARKET REVENUE, BY END-USERS, (2013-2021) ($MN)
Table 81 NEW PRODUCT LAUNCHES (2013-2015)
Table 82 AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES (2013-2015)
Table 83 APPROVALS (2013-2015)
Table 84 MERGERS & ACQUISITIONS (2013-2015)
Table 85 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN)
Table 86 ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 87 ABBOTT LABORATORIES: REVENUE SEGMENTS OF MEDICAL DEVICES, (2013-2014)($MN)
Table 88 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 89 NOVARTIS: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN)
Table 90 NOVARTIS AG: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 91 NOVARTIS AG: SEGMENTAL REVENUE OF ALCON LABORATORIES, (2012-2014) ($MN)
Table 92 NOVARTIS AG: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 93 VALEANT PHARMACEUTICAL INTERNATIONAL, INC: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN)
Table 94 VALEANT PHARMACEUTICAL INTERNATIONAL, INC: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 95 VALEANT PHARMACEUTICAL INTERNATIONAL, INC: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 96 CARL ZEISS AG: TOTAL SALES AND R&D EXPENSES (2012-2014) ($MN)
Table 97 CARL ZEISS: TOTAL SALES, BY SEGMENTS, (2012-2014) ($MN)
Table 98 CARL ZEISS: TOTAL SALES, BY GEOGRAPHY, (2012-2014) ($MN)
Table 99 ESSILOR: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN)
Table 100 ESSILOR INTERNATIONAL: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 101 ESSILOR INTERNATIONAL: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 102 HOYA CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2012-2014) ($MN)
Table 103 HOYA CORPORATION: TOTAL REVENUE, BY SEGMENTS (2012-2014) ($MN)
Table 104 HOYA CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2012-2014) ($MN)
Table 105 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES (2012-2014) ($MN)
Table 106 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 107 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 108 STAAR SURGICAL COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN)
Table 109 STAAR SURGICAL COMPANY: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 110 STAAR SURGICAL COMPANY: TOTAL REVENUE, BY GEOGRAPHY (2012-2014) ($MN)
Table 111 TOPCON CORPORAION.: TOTAL SALES AND R&D EXPENSES (2012-2014) ($MN)
Table 112 TOPCON CORPORATION: TOTAL SALES, BY SEGMENTS, (2012-2014) ($MN)
Table 113 TOPCON CORPORATION: TOTAL SALES, BY GEOGRAPHY, (2012-2014) ($MN)
Table 1 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 2 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2013-2021) ($MN)
Table 3 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY APPLICATIONS, (2013-2021) ($MN)
Table 4 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2013-2021) ($MN)
Table 5 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2013-2021) ($MN)
Table 6 DIAGNOSTIC DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 7 AUTOREFRACTOMETER GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 8 SLIT LAMP GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 9 TONOMETERS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 10 OPHTHALMOSCOPE GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 11 KERATOMETER GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 12 CORNEAL TOPOGRAPHER GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 13 OPTICAL COHERENCE TOMOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 14 FUNDUS CAMERA GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 15 FUNDUS CAMERA GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 16 NON-MYDRIATIC FUNDUS CAMERA GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 17 MYDRIATIC FUNDUS CAMERA GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 18 HYBRID FUNDUS CAMERA GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 19 RETINOPATHY OF PREMATURITY GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 20 OPHTHALMIC ULTRASOUND IMAGING SYSTEM GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 21 RETINOSCOPE GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 22 PERIMETER GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 23 PACHYMETER GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 24 OTHERS (DIAGNOSTICS) GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 25 SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 26 SURGICAL DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 27 CATARACT SURGICAL DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 28 CATARACT SURGERY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 29 IOL GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 30 PHACOEMULSIFICATION GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 31 OVD GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 32 GLACOMA SURGERY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 33 REFRACTIVE SURGERY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 34 VITREORETINAL SURGERY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 35 VISION CARE GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 36 VISION CARE GLOBAL MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 37 SPECTACLE LENSES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 38 CONTACT LENSES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 39 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN)
Table 40 CATARACT GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 41 GLAUCOMA GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 42 AGE RELATED MACULAR DEGENERATION MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 43 DIABETIC RETINOPATHY GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 44 OTHERS (APPLICATIONS) GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 45 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2013-2021) ($MN)
Table 46 HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 47 ACADEMICS & RESEARCH LABORATORIES GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 48 OTHER END USERS GLOBAL MARKET REVENUE, BY REGION, (2013-2021) ($MN)
Table 49 NORTH AMERICAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2013-2021) ($MN)
Table 50 NORTH AMERICAN DIAGNOSTIC DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 51 NORTH AMERICAN FUNDUS CAMERAS MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 52 NORTH AMERICAN SURGICAL DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 53 NORTH AMERICAN CATARACT SURGERY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 54 NORTH AMERICAN VISION CARE MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 55 NORTH AMERICAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN)
Table 56 NORTH AMERICAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY END-USER, (2013-2021) ($MN)
Table 57 EUROPEAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 58 EUROPEAN DIAGNOSTIC DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 59 EUROPEAN FUNDUS CAMERAS MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 60 EUROPEAN SURGICAL DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 61 EUROPEAN CATARACT SURGERY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 62 EUROPEAN VISION CARE MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 63 EUROPEAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN)
Table 64 EUROPEAN OPHTHALMOLOGY DEVICES MARKET REVENUE, BY END-USERS, (2013-2021) ($MN)
Table 65 ASIA-PACIFIC OPHTHALMOLOGY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 66 ASIA-PACIFIC DIAGNOSTIC DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 67 ASIA-PACIFIC FUNDUS CAMERAS MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 68 ASIA-PACIFIC SURGICAL DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 69 ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 70 ASIA-PACIFIC VISION CARE MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 71 ASIA-PACIFIC OPHTHALMOLOGY DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN)
Table 72 ASIA-PACIFIC OPHTHALMOLOGY DEVICES MARKET REVENUE, BY END-USERS, (2013-2021) ($MN)
Table 73 ROW OPHTHALMOLOGY DEVICES MARKET REVENUE, BY TYPE (2013-2021) ($MN)
Table 74 ROW DIAGNOSTICS DEVICES MARKET REVENUE, BY TYPES, (2013-2021) ($MN)
Table 75 ROW FUNDUS CAMERAS MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 76 ROW SURGICAL DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 77 ROW CATARACT SURGERY DEVICES MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 78 ROW VISION CARE MARKET REVENUE, BY TYPE, (2013-2021) ($MN)
Table 79 ROW OPHTHALMOLOGY DEVICES MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN)
Table 80 ROW OPHTHALMOLOGY DEVICES MARKET REVENUE, BY END-USERS, (2013-2021) ($MN)
Table 81 NEW PRODUCT LAUNCHES (2013-2015)
Table 82 AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES (2013-2015)
Table 83 APPROVALS (2013-2015)
Table 84 MERGERS & ACQUISITIONS (2013-2015)
Table 85 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN)
Table 86 ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 87 ABBOTT LABORATORIES: REVENUE SEGMENTS OF MEDICAL DEVICES, (2013-2014)($MN)
Table 88 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 89 NOVARTIS: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN)
Table 90 NOVARTIS AG: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 91 NOVARTIS AG: SEGMENTAL REVENUE OF ALCON LABORATORIES, (2012-2014) ($MN)
Table 92 NOVARTIS AG: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 93 VALEANT PHARMACEUTICAL INTERNATIONAL, INC: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN)
Table 94 VALEANT PHARMACEUTICAL INTERNATIONAL, INC: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 95 VALEANT PHARMACEUTICAL INTERNATIONAL, INC: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 96 CARL ZEISS AG: TOTAL SALES AND R&D EXPENSES (2012-2014) ($MN)
Table 97 CARL ZEISS: TOTAL SALES, BY SEGMENTS, (2012-2014) ($MN)
Table 98 CARL ZEISS: TOTAL SALES, BY GEOGRAPHY, (2012-2014) ($MN)
Table 99 ESSILOR: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN)
Table 100 ESSILOR INTERNATIONAL: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 101 ESSILOR INTERNATIONAL: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 102 HOYA CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2012-2014) ($MN)
Table 103 HOYA CORPORATION: TOTAL REVENUE, BY SEGMENTS (2012-2014) ($MN)
Table 104 HOYA CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2012-2014) ($MN)
Table 105 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES (2012-2014) ($MN)
Table 106 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 107 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
Table 108 STAAR SURGICAL COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN)
Table 109 STAAR SURGICAL COMPANY: TOTAL REVENUE, BY SEGMENTS, (2012-2014) ($MN)
Table 110 STAAR SURGICAL COMPANY: TOTAL REVENUE, BY GEOGRAPHY (2012-2014) ($MN)
Table 111 TOPCON CORPORAION.: TOTAL SALES AND R&D EXPENSES (2012-2014) ($MN)
Table 112 TOPCON CORPORATION: TOTAL SALES, BY SEGMENTS, (2012-2014) ($MN)
Table 113 TOPCON CORPORATION: TOTAL SALES, BY GEOGRAPHY, (2012-2014) ($MN)
LIST OF FIGURES
Figure 1 GLOBAL OPHTHALMOLOGY DEVICES MARKET SHARE AND REVENUE, BY REGION (2013-2021)
Figure 2 RESEARCH METHODOLOGY: OPHTHALMOLOGY DEVICES GLOBAL MARKET
Figure 3 OPHTHALMOLOGY DEVICES MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 OPHTHALMOLOGY DEVICES MARKET: FORECASTING MODEL
Figure 5 OPHTHALMOLOGY DEVICES MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
Figure 6 OPHTHALMOLOGY DEVICES MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 OPHTHALMOLOGY DEVICES MARKET:PATENT FILING BY MAJOR PLAYERS (2010-2015)
Figure 9 OPHTHALMOLOGY DEVICES MARKET:PATENT FILING BY SEGMENT, (2010-2015)
Figure 10 OPHTHALMOLOGY DEVICES MARKET: PORTER’S ANALYSIS
Figure 11 OPHTHALMOLOGY DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2014
Figure 12 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2014 V’S 2021) ($MN)
Figure 13 GLOBAL OPHTHALMOLOGY DEVICE MARKET REVENUE, BY SURGERY (2014 V’S 2021) ($MN)
Figure 14 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY APPLICATION (2014 V’S 2021) ($MN)
Figure 15 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY END USERS (2013 V’S 2021) ($MN)
Figure 16 GLOBAL OPHTHALMOLOGY DEVICES MARKET REVENUE, BY REGION (2013-2021) ($MN)
Figure 17 NORTH AMERICAN OPHTHALMOLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, APPLICATION & END-USER OUTLOOK, (2014 V’S 2021)
Figure 18 EUROPEAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, APPLICATION & END-USER OUTLOOK, (2014 V’S 2021)
Figure 19 ASIA-PACIFIC OPHTHMOLOGY DEVICES MARKET SIZE, BY TYPE, PRODUCT, APPLICATION & END-USER OUTLOOK, (2014 V’S 2021)
Figure 20 ROW OPHTHMOLOGY DEVICES MARKET SIZE, BY TYPE, PRODUCT, APPLICATION & END-USER OUTLOOK, (2014 V’S 2021)
Figure 21 KEY GROWTH STRATEGIES, (2013-2015)
Figure 22 SWOT: ABBOTT LABORATORIES
Figure 23 SWOT: ALCON LABORATORIES.
Figure 24 SWOT: VALEANT PHARMACEUTICALS INTERNATIONAL
Figure 25 SWOT: CARL ZEISS
Figure 26 SWOT: ESSILOR INTERNATIONAL
Figure 27 SWOT: HAAG-STREIT AG
Figure 28 SWOT: HOYA CORPORATION
Figure 29 SWOT: JOHNSON & JOHNSON
Figure 30 SWOT: STAAR SURGICAL COMPANY
Figure 31 SWOT: TOPCON CORPORATION
LIST OF ACRONYMS
Acronym Expanded form
AAO America Academy of Ophthalmology
AAPOS American Association of Paediatric Ophthalmology and Strabismus
AIMDD Active Implantable Medical Device Directive
AMD Age Related Macular Degeneration
AMO Abbott Medical Optics
B&L Bausch and Lomb
CDC Centre for Disease Control and Development
CDRH Centre for Devices and Radiological Health
CDSCO Central Drug Standard Control Organization
CE Conformity Europeans
CFDA China Food and Drug Administration
CLAA Central Licensing Approval Authority
CLAO Contact Lens Association of Ophthalmologists
CMOs Contract Manufacturing Organization
CROs Contract Research Organizations
CTS Common Technical Specifications
DME Diabetic Macular Edema
DR Diabetic Retinopathy
DWFS Deconvolution Wave front Sensing
EIU Economist Intelligence Unit
EU European Union
FDA Food and Drug Administration
FFA Fundus Fluorescien Angiography
GMP Good Manufacturing Practice
GPOs Group Purchasing Organizations
GRF Glaucoma Research Foundation
HHS Department of Health and Human Services
HPO High Performance Optics
ICEH International Center for Eye Health
ICO International Council of Ophthalmology
IOL Intraocular Lenses
IOP Intraocular Pressure
JMDN Japan Medical Device Nomenclature
JOIA Japan Ophthalmic Instruments Association
LAL Light Adjustable Lens
LASEK Laser Assisted Sub-Epithelium Keratomileusis
LASIK Laser Assisted Insitu Keratomileusis
LATAM Latin America
LCD Liquid Crystal Display
LED Light Emitting Diodes
MAH Market Authorization Holder
MDD Medical Device Directive
MHLW Ministry of Health, Labor and Welfare
MIGS Minimal Invasive Glaucoma Surgery
MPF Medicare Physician Fee
OAG Open-Angle Glaucoma
OCT Optical Coherence Tomography
ODE Office of Device Evolution
OECD Organization of Economic Cooperation and Development
OEM Original Equipment Manufacturers
OVD Ophthalmic Viscoelastic Devices
PAL Pharmaceutical Affairs Law
PIOL Phakic Intraocular Lens
PMA Pre Market Approval
PMDA Pharmaceutical and Medical Devices Agency
PPACA Patient Protection and Affordable Care Act
PRK Photorefractive keratectomy
QS Quality System
R&D Research and Development
RCB Registered Certified Body
RK Radial Keratotomy
RLE Refractive Lens Exchange
ROP Retinopathy of Prematurity
RoW Rest of the World
SD-OCT Spectral Domain Optical Coherence Tomography
SEC Security and Exchange Commission
SFDA State Food and Drug Administration
SOE European Society of Ophthalmology
STED Summary Technical Document
U.S. United States of America
UK United Kingdom
UV Ultra-Violet
VEGF Vascular Endothelial Growth Factor
VST Vision Shaping Treatment
WHO World Health Organization
Figure 1 GLOBAL OPHTHALMOLOGY DEVICES MARKET SHARE AND REVENUE, BY REGION (2013-2021)
Figure 2 RESEARCH METHODOLOGY: OPHTHALMOLOGY DEVICES GLOBAL MARKET
Figure 3 OPHTHALMOLOGY DEVICES MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 OPHTHALMOLOGY DEVICES MARKET: FORECASTING MODEL
Figure 5 OPHTHALMOLOGY DEVICES MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
Figure 6 OPHTHALMOLOGY DEVICES MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 OPHTHALMOLOGY DEVICES MARKET:PATENT FILING BY MAJOR PLAYERS (2010-2015)
Figure 9 OPHTHALMOLOGY DEVICES MARKET:PATENT FILING BY SEGMENT, (2010-2015)
Figure 10 OPHTHALMOLOGY DEVICES MARKET: PORTER’S ANALYSIS
Figure 11 OPHTHALMOLOGY DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2014
Figure 12 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2014 V’S 2021) ($MN)
Figure 13 GLOBAL OPHTHALMOLOGY DEVICE MARKET REVENUE, BY SURGERY (2014 V’S 2021) ($MN)
Figure 14 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY APPLICATION (2014 V’S 2021) ($MN)
Figure 15 OPHTHALMOLOGY DEVICES GLOBAL MARKET REVENUE, BY END USERS (2013 V’S 2021) ($MN)
Figure 16 GLOBAL OPHTHALMOLOGY DEVICES MARKET REVENUE, BY REGION (2013-2021) ($MN)
Figure 17 NORTH AMERICAN OPHTHALMOLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, APPLICATION & END-USER OUTLOOK, (2014 V’S 2021)
Figure 18 EUROPEAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, APPLICATION & END-USER OUTLOOK, (2014 V’S 2021)
Figure 19 ASIA-PACIFIC OPHTHMOLOGY DEVICES MARKET SIZE, BY TYPE, PRODUCT, APPLICATION & END-USER OUTLOOK, (2014 V’S 2021)
Figure 20 ROW OPHTHMOLOGY DEVICES MARKET SIZE, BY TYPE, PRODUCT, APPLICATION & END-USER OUTLOOK, (2014 V’S 2021)
Figure 21 KEY GROWTH STRATEGIES, (2013-2015)
Figure 22 SWOT: ABBOTT LABORATORIES
Figure 23 SWOT: ALCON LABORATORIES.
Figure 24 SWOT: VALEANT PHARMACEUTICALS INTERNATIONAL
Figure 25 SWOT: CARL ZEISS
Figure 26 SWOT: ESSILOR INTERNATIONAL
Figure 27 SWOT: HAAG-STREIT AG
Figure 28 SWOT: HOYA CORPORATION
Figure 29 SWOT: JOHNSON & JOHNSON
Figure 30 SWOT: STAAR SURGICAL COMPANY
Figure 31 SWOT: TOPCON CORPORATION
LIST OF ACRONYMS
Acronym Expanded form
AAO America Academy of Ophthalmology
AAPOS American Association of Paediatric Ophthalmology and Strabismus
AIMDD Active Implantable Medical Device Directive
AMD Age Related Macular Degeneration
AMO Abbott Medical Optics
B&L Bausch and Lomb
CDC Centre for Disease Control and Development
CDRH Centre for Devices and Radiological Health
CDSCO Central Drug Standard Control Organization
CE Conformity Europeans
CFDA China Food and Drug Administration
CLAA Central Licensing Approval Authority
CLAO Contact Lens Association of Ophthalmologists
CMOs Contract Manufacturing Organization
CROs Contract Research Organizations
CTS Common Technical Specifications
DME Diabetic Macular Edema
DR Diabetic Retinopathy
DWFS Deconvolution Wave front Sensing
EIU Economist Intelligence Unit
EU European Union
FDA Food and Drug Administration
FFA Fundus Fluorescien Angiography
GMP Good Manufacturing Practice
GPOs Group Purchasing Organizations
GRF Glaucoma Research Foundation
HHS Department of Health and Human Services
HPO High Performance Optics
ICEH International Center for Eye Health
ICO International Council of Ophthalmology
IOL Intraocular Lenses
IOP Intraocular Pressure
JMDN Japan Medical Device Nomenclature
JOIA Japan Ophthalmic Instruments Association
LAL Light Adjustable Lens
LASEK Laser Assisted Sub-Epithelium Keratomileusis
LASIK Laser Assisted Insitu Keratomileusis
LATAM Latin America
LCD Liquid Crystal Display
LED Light Emitting Diodes
MAH Market Authorization Holder
MDD Medical Device Directive
MHLW Ministry of Health, Labor and Welfare
MIGS Minimal Invasive Glaucoma Surgery
MPF Medicare Physician Fee
OAG Open-Angle Glaucoma
OCT Optical Coherence Tomography
ODE Office of Device Evolution
OECD Organization of Economic Cooperation and Development
OEM Original Equipment Manufacturers
OVD Ophthalmic Viscoelastic Devices
PAL Pharmaceutical Affairs Law
PIOL Phakic Intraocular Lens
PMA Pre Market Approval
PMDA Pharmaceutical and Medical Devices Agency
PPACA Patient Protection and Affordable Care Act
PRK Photorefractive keratectomy
QS Quality System
R&D Research and Development
RCB Registered Certified Body
RK Radial Keratotomy
RLE Refractive Lens Exchange
ROP Retinopathy of Prematurity
RoW Rest of the World
SD-OCT Spectral Domain Optical Coherence Tomography
SEC Security and Exchange Commission
SFDA State Food and Drug Administration
SOE European Society of Ophthalmology
STED Summary Technical Document
U.S. United States of America
UK United Kingdom
UV Ultra-Violet
VEGF Vascular Endothelial Growth Factor
VST Vision Shaping Treatment
WHO World Health Organization
